Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Cancer Cell2015Vol. 27(4), pp. 516–532
Citations Over TimeTop 1% of 2015 papers
Ramona Crescenzo, Francesco Abate, Elena Lasorsa, Fabrizio Tabbò, Marcello Gaudiano, Nicoletta Chiesa, Filomena Di Giacomo, Elisa Spaccarotella, Luigi Barbarossa, Elisabetta Ercole, Maria Chiara Todaro, Michela Boi, Andrea Acquaviva, Elisa Ficarra, Domenico Novero, Andrea Rinaldi, Thomas Tousseyn, Andreas Rosenwald, Lukas Kenner, Lorenzo Cerroni, Alexandar Tzankov, Maurilio Ponzoni, Marco Paulli, Dennis D. Weisenburger, Wing C. Chan, Javeed Iqbal, Miguel Á. Piris, Alberto Zamò, Carmela Ciardullo, Davide Rossi, Gianluca Gaïdano, Stefano Pileri, Enrico Tiacci, Brunangelo Falini, Leonard D. Shultz, Laurence Mévellec, Jorge Vialard, Roberto Piva, Francesco Bertoni, Raúl Rabadán, Giorgio Inghirami
Related Papers
- → Treatment of Refractory ALK Rearranged Anaplastic Large Cell Lymphoma With Alectinib(2019)15 cited
- → From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL)(2017)10 cited
- → Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma(2019)7 cited
- → Anaplastic large cell lymphoma, ALK-positive and anaplastic large cell lymphoma ALK-negative(2009)8 cited
- → An Exploration into the Origins and Pathogenesis of Anaplastic Large Cell Lymphoma, Anaplastic Lymphoma Kinase (ALK)-Positive(2017)7 cited